marimastat has been researched along with Liver Cirrhosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de Meijer, VE; Le, HD; Meisel, JA; Nosé, V; Popov, Y; Puder, M; Schuppan, D; Sverdlov, DY | 1 |
1 other study(ies) available for marimastat and Liver Cirrhosis
Article | Year |
---|---|
Broad-spectrum matrix metalloproteinase inhibition curbs inflammation and liver injury but aggravates experimental liver fibrosis in mice.
Topics: Alanine Transaminase; Animals; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Down-Regulation; Hydroxamic Acids; Liver Cirrhosis; Matrix Metalloproteinase Inhibitors; Mice; Protease Inhibitors; Reverse Transcriptase Polymerase Chain Reaction | 2010 |